• Subscribe Now
  • Rankings
  • Magazine
  • Newsletters
  • Podcasts
  • Video On Demand
  • Fortune Live Media
  • Fortune Connect
  • Fortune Education
  • Fortune Well
  • Fortune Crypto
  • Fortune Recommends
  • Rankings
    • See All Rankings
    • Fortune 500
    • Global 500
    • 40 Under 40
    • GREAT PLACE TO WORK LISTS
    • Best MBA Programs
  • Magazine
    • April/May 2023
    • February/March 2023
    • December 2022/January 2023
    • October/November 2022
  • Newsletters
  • Podcasts
  • More
    • Video On Demand
    • Fortune Live Media
    • Fortune Connect
    • Fortune Education
    • Fortune Well
    • Fortune Crypto
    • Fortune Recommends
Subscribe Now

turing

  • TechWeb Maestro Tim Berners-Lee Wins Prestigious Tech Award
    BYBarb Darrow
  • Fortune Global Forum 2015
    LeadershipMeet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals
    BYBill George
  • Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
    HealthThe FTC Is Probing Martin Shkreli’s Former Company Over its Drug Prices
    BYReuters
  • VW Automobile Assembly
    LeadershipThe 5 Biggest Corporate Scandals of 2015
    BYChris Matthews and Stephen Gandel
  • Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
    HealthAftershocks Keep Coming After Former Pharma CEO’s Arrest
    BYReuters
  • Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
    HealthMartin Shkreli Says This Is the Real Reason He Was Arrested
    BYMichal Addady
  • Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
    LeadershipMartin Shkreli’s 15 Minutes Are Up
    BYGeoff Colvin
  • Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
    FinanceAccused Pharma CEO Martin Shkreli: ‘My Investors Made Lots Of Money’
    BYJen Wieczner
  • Janet Yellen Testifies Before House Financial Services Committee
    FinanceEnd of Easy Money Brings Relief
    BYAlan Murray
  • HealthThis Is What Happens When Cheap Drugs Get Wildly Expensive
    BYLaura Lorenzetti
  • Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
    LeadershipMylan, Valeant and Theranos: What the Heck, Biotech?
    BYJeffrey Sonnenfeld
  • MSMB Capital Management CIO Martin Shkreli
    HealthRecord label cuts ties with besieged pharma CEO Martin Shkreli
    BYDaniel Roberts

Most Popular

  • Finance
    The housing market is so broken that many 40- and 30-something millennials have no choice but to build homes in their...
    BYJeff Kruth, Murali Paranandi, and others
  • Success
    Ultrawealthy heterosexual couples are living like the 1950s never ended, according to research of 30 years of data
    BYJill Yavorsky, Sarah Thebaud, and others
  • Leadership
    Martha Stewart says America will ‘go down the drain’ if remote work continues—and calls France ‘stupid for having...
    BYEleanor Pringle
Rankings
  • 40 Under 40
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Most Powerful Women
  • World’s Greatest Leaders
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Well
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • Conferences
  • Personal Finance
  • Recommends
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Advertising
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Work at Fortune
  • Behavioral Advertising Notice
  • Terms and Conditions
  • Site Map

© 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information | Ad Choices 
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.